The global vaccine adjuvants market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for vaccines in emerging economies and the growing awareness about vaccination among people. The human vaccine adjuvants segment is expected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030, due to increasing demand for vaccines in emerging economies and growing awareness about vaccination among people.
The global vaccine adjuvants market has been segmented on the basis of type into oral, subcutaneous, intramuscular; on the basis of application into veterinary vaccine adjuvants (research applications and commercial applications) and human vaccine adjuvants (research applications and commercial applications); and on the basis of region into North America, Latin America, Europe, Asia Pacific & Middle East & Africa.
- The increasing awareness about the benefits of vaccination among parents and healthcare providers is also expected to fuel the growth of this market during the forecast period.
- The growing number of vaccines being developed for various indications will also contribute significantly towards driving this market over the next few years .
Industry Growth Insights published a new data on “Vaccine Adjuvants Market”. The research report is titled “Vaccine Adjuvants Market research by Types (Oral, Subcutaneous, Intramuscular, Others), By Applications (Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications), Human Vaccine Adjuvants (Research Applications, Commercial Applications)), By Players/Companies SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, SEPPIC, SPI Pharma, Novavax, Avanti Polar Lipids, Aphios”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccine Adjuvants Market Research Report
By Type
Oral, Subcutaneous, Intramuscular, Others
By Application
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications), Human Vaccine Adjuvants (Research Applications, Commercial Applications)
By Companies
SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, SEPPIC, SPI Pharma, Novavax, Avanti Polar Lipids, Aphios
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Vaccine Adjuvants Market Report Segments:
The global Vaccine Adjuvants market is segmented on the basis of:
Types
Oral, Subcutaneous, Intramuscular, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications), Human Vaccine Adjuvants (Research Applications, Commercial Applications)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SEPPIC
- SDA BIO
- Croda International Plc
- SPI Pharma
- Phibro Animal Health Corporation
- Tj Kaiwei
- Novavax
- Zhuoyue
- Aphios
- GSK
- CSL Limited
- Brenntag Biosector
- SEPPIC
- SPI Pharma
- Novavax
- Avanti Polar Lipids
- Aphios
Highlights of The Vaccine Adjuvants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Subcutaneous
- Intramuscular
- Others
- By Application:
- Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
- Human Vaccine Adjuvants (Research Applications, Commercial Applications)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccine Adjuvants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Adjuvants are substances that help increase the effectiveness of vaccines. They can be either active (such as aluminum salts) or passive (such as oil-based emulsions).
Some of the major players in the vaccine adjuvants market are SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, SEPPIC, SPI Pharma, Novavax, Avanti Polar Lipids, Aphios.
The vaccine adjuvants market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vaccine Adjuvants Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vaccine Adjuvants Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vaccine Adjuvants Market - Supply Chain
4.5. Global Vaccine Adjuvants Market Forecast
4.5.1. Vaccine Adjuvants Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vaccine Adjuvants Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vaccine Adjuvants Market Absolute $ Opportunity
5. Global Vaccine Adjuvants Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vaccine Adjuvants Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Subcutaneous
5.3.3. Intramuscular
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vaccine Adjuvants Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vaccine Adjuvants Market Size and Volume Forecast by Application
6.3.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
6.3.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vaccine Adjuvants Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vaccine Adjuvants Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vaccine Adjuvants Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vaccine Adjuvants Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vaccine Adjuvants Demand Share Forecast, 2019-2026
9. North America Vaccine Adjuvants Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vaccine Adjuvants Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vaccine Adjuvants Market Size and Volume Forecast by Application
9.4.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
9.4.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vaccine Adjuvants Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Subcutaneous
9.7.3. Intramuscular
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vaccine Adjuvants Demand Share Forecast, 2019-2026
10. Latin America Vaccine Adjuvants Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vaccine Adjuvants Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vaccine Adjuvants Market Size and Volume Forecast by Application
10.4.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
10.4.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vaccine Adjuvants Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Subcutaneous
10.7.3. Intramuscular
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vaccine Adjuvants Demand Share Forecast, 2019-2026
11. Europe Vaccine Adjuvants Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vaccine Adjuvants Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vaccine Adjuvants Market Size and Volume Forecast by Application
11.4.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
11.4.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vaccine Adjuvants Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Subcutaneous
11.7.3. Intramuscular
11.7.. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vaccine Adjuvants Demand Share, 2019-2026
12. Asia Pacific Vaccine Adjuvants Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vaccine Adjuvants Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vaccine Adjuvants Market Size and Volume Forecast by Application
12.4.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
12.4.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vaccine Adjuvants Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Subcutaneous
12.7.3. Intramuscular
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vaccine Adjuvants Demand Share, 2019-2026
13. Middle East & Africa Vaccine Adjuvants Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vaccine Adjuvants Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vaccine Adjuvants Market Size and Volume Forecast by Application
13.4.1. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
13.4.2. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vaccine Adjuvants Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Subcutaneous
13.7.3. Intramuscular
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vaccine Adjuvants Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vaccine Adjuvants Market: Market Share Analysis
14.2. Vaccine Adjuvants Distributors and Customers
14.3. Vaccine Adjuvants Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SEPPIC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SDA BIO
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Croda International Plc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. SPI Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Phibro Animal Health Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tj Kaiwei
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novavax
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhuoyue
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Aphios
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GSK
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CSL Limited
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Brenntag Biosector
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. SEPPIC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. SPI Pharma
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Novavax
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Avanti Polar Lipids
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Aphios
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
